Niranjan Yanamandra

2.5k total citations
28 papers, 823 citations indexed

About

Niranjan Yanamandra is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Niranjan Yanamandra has authored 28 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Niranjan Yanamandra's work include Cancer Immunotherapy and Biomarkers (10 papers), Protease and Inhibitor Mechanisms (8 papers) and Immunotherapy and Immune Responses (5 papers). Niranjan Yanamandra is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Protease and Inhibitor Mechanisms (8 papers) and Immunotherapy and Immune Responses (5 papers). Niranjan Yanamandra collaborates with scholars based in United States, India and United Kingdom. Niranjan Yanamandra's co-authors include William C. Olivero, Dzung H. Dinh, Meena Gujrati, Jasti S. Rao, Christopher S. Gondi, Santhi D. Konduri, Sajani S. Lakka, Shakuntala Kondraganti, Robert Buzzeo and Darrin M. Beaupre and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Niranjan Yanamandra

26 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niranjan Yanamandra United States 18 441 265 265 155 122 28 823
Laura A. Rudolph‐Owen United States 10 763 1.7× 361 1.4× 336 1.3× 94 0.6× 126 1.0× 12 1.2k
David F. Allison United States 14 1.2k 2.7× 235 0.9× 203 0.8× 115 0.7× 144 1.2× 16 1.4k
Kati Takaluoma Finland 10 350 0.8× 308 1.2× 119 0.4× 89 0.6× 140 1.1× 10 732
Kym L. Stanley Australia 9 588 1.3× 310 1.2× 123 0.5× 103 0.7× 107 0.9× 10 893
Fabienne Maurer Switzerland 15 598 1.4× 151 0.6× 147 0.6× 90 0.6× 81 0.7× 24 916
Antonella Tacconelli Italy 15 487 1.1× 232 0.9× 327 1.2× 58 0.4× 79 0.6× 24 820
Paola Franco Italy 20 515 1.2× 318 1.2× 637 2.4× 189 1.2× 100 0.8× 51 1.2k
Ludmila Szabova United States 13 325 0.7× 241 0.9× 249 0.9× 58 0.4× 80 0.7× 21 682
Rui Fang Qiao United States 11 999 2.3× 360 1.4× 201 0.8× 45 0.3× 83 0.7× 12 1.3k
Yin Xu United States 11 600 1.4× 230 0.9× 173 0.7× 27 0.2× 82 0.7× 15 858

Countries citing papers authored by Niranjan Yanamandra

Since Specialization
Citations

This map shows the geographic impact of Niranjan Yanamandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niranjan Yanamandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niranjan Yanamandra more than expected).

Fields of papers citing papers by Niranjan Yanamandra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niranjan Yanamandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niranjan Yanamandra. The network helps show where Niranjan Yanamandra may publish in the future.

Co-authorship network of co-authors of Niranjan Yanamandra

This figure shows the co-authorship network connecting the top 25 collaborators of Niranjan Yanamandra. A scholar is included among the top collaborators of Niranjan Yanamandra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niranjan Yanamandra. Niranjan Yanamandra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davar, Diwakar, Zeynep Eroglu, Niranjan Yanamandra, et al.. (2025). Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Melanoma: AMBER Cohorts 1c, 1e, and 2A. Clinical Cancer Research. 31(16). 3433–3442. 2 indexed citations
2.
Samant, Tanay S., Herbert Struemper, Morris Muliaditan, et al.. (2024). P4.11E.28 Pharmacological Comparison of Dostarlimab and Pembrolizumab in Metastatic Non-Small Cell Lung Cancer in PERLA. Journal of Thoracic Oncology. 19(10). S407–S408.
3.
Yanamandra, Niranjan, et al.. (2022). Innate immunity as a target for novel therapeutics in triple negative breast cancer. Expert Opinion on Investigational Drugs. 31(8). 781–794. 1 indexed citations
4.
Peng, Weiyi, Leila J. Williams, Chunyu Xu, et al.. (2019). Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma. Clinical Cancer Research. 25(21). 6406–6416. 33 indexed citations
5.
Massarelli, Erminia, Vincent K. Lam, Edwin R. Parra, et al.. (2019). High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 7(1). 351–351. 41 indexed citations
6.
Niknam, Sharareh, Hampartsoum B. Barsoumian, Jonathan E. Schoenhals, et al.. (2018). Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model. Clinical Cancer Research. 24(22). 5735–5743. 46 indexed citations
7.
Bhattacharya, Sabyasachi, Paul Bojczuk, David Kilian, et al.. (2018). Evaluation of OX40 receptor density, influence of IgG Isotype and dosing paradigm in anti-OX40-mediated efficacy and biomarker responses with PD-1 blockade. Annals of Oncology. 29. viii424–viii425.
8.
Yanamandra, Niranjan, Robert Buzzeo, Mark C. Gabriel, et al.. (2011). Tipifarnib-Induced Apoptosis in Acute Myeloid Leukemia and Multiple Myeloma Cells Depends on Ca2+ Influx through Plasma Membrane Ca2+ Channels. Journal of Pharmacology and Experimental Therapeutics. 337(3). 636–643. 34 indexed citations
9.
Gondi, Christopher S., et al.. (2006). Regression of pre-established intracranial tumor growth by ON 01910.Na, a selective anticancer agent currently in phase I trials. Journal of Clinical Oncology. 24(18_suppl). 1576–1576. 3 indexed citations
10.
Reddy, C. Damodar, Ratnakar Patti, Asha Guttapalli, et al.. (2005). Anticancer effects of the novel 1α, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastoma. Journal of Cellular Biochemistry. 97(1). 198–206. 26 indexed citations
11.
Yanamandra, Niranjan, Shakuntala Kondraganti, Christopher S. Gondi, et al.. (2005). Recombinant adeno‐associated virus (rAAV) expressing TFPI‐2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line. International Journal of Cancer. 115(6). 998–1005. 53 indexed citations
12.
Yanamandra, Niranjan, Mark A. Berhow, Santhi D. Konduri, et al.. (2003). Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells. Clinical & Experimental Metastasis. 20(4). 375–383. 21 indexed citations
13.
Konduri, Santhi D., Kalkunte S. Srivenugopal, Niranjan Yanamandra, et al.. (2003). Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), in human glioma cells. Oncogene. 22(29). 4509–4516. 70 indexed citations
14.
Siddique, Khawar, et al.. (2003). Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas. International Journal of Oncology. 22(2). 289–94. 27 indexed citations
15.
Konduri, Santhi D., Niranjan Yanamandra, Dzung H. Dinh, et al.. (2003). Physiological and chemical inducers of tissue factor pathway inhibitor-2 in human glioma cells. International Journal of Oncology. 22(6). 1277–83. 15 indexed citations
16.
Everman, David B., Cynthia F. Bartels, Yue Yang, et al.. (2002). The mutational spectrum of brachydactyly type C. American Journal of Medical Genetics. 112(3). 291–296. 65 indexed citations
17.
Konduri, Santhi D., Niranjan Yanamandra, Khawar Siddique, et al.. (2002). Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene. 21(57). 8705–8712. 63 indexed citations
18.
Konduri, Santhi D., Sajani S. Lakka, Αναστασία Τάσιου, et al.. (2001). Elevated levels of cathepsin B in human glioblastoma cell lines. International Journal of Oncology. 19(3). 519–24. 29 indexed citations
19.
Τάσιου, Αναστασία, Santhi D. Konduri, Niranjan Yanamandra, et al.. (2001). A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas. International Journal of Oncology. 19(3). 591–7. 29 indexed citations
20.
Yanamandra, Niranjan, Santhi D. Konduri, Sanjeeva Mohanam, et al.. (2000). Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells. Clinical & Experimental Metastasis. 18(7). 611–615. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura A. Rudolph‐Owen Breakdown of academic impact, for papers by David F. Allison Breakdown of academic impact, for papers by Kati Takaluoma Breakdown of academic impact, for papers by Kym L. Stanley Breakdown of academic impact, for papers by Fabienne Maurer Breakdown of academic impact, for papers by Antonella Tacconelli Breakdown of academic impact, for papers by Paola Franco Breakdown of academic impact, for papers by Ludmila Szabova Breakdown of academic impact, for papers by Rui Fang Qiao Breakdown of academic impact, for papers by Yin Xu
Rankless by CCL
2026